BioPharma Drug Discovery
WuXi Biologics Secures UK MHRA GMP Clearance For Wuxi Ophthalmic Manufacturing Sites
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing ...
January 14, 2026 | News
TetraScience And Thermo Fisher Join Forces To Accelerate Scientific AI Across Biopharma
TetraScience, the Scientific Data and AI company, announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, with a...
January 14, 2026 | News
Thermo Fisher And NVIDIA Join Forces To Build The AI Powered Laboratory Of The Future
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions...
January 13, 2026 | News
Clover Advances Global First In Class Respiratory Vaccine Strategy With Phase Two Launch
- Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover's Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candid...
January 13, 2026 | News
China Approves ArkBio Aizhida For ADHD With Rapid Onset And All Day Symptom Control
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the...
January 12, 2026 | News
Pierre Fabre Laboratories And Iktos Launch AI Driven Oncology Drug Discovery Alliance
Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, announced an integrated drug disc...
January 12, 2026 | News
M&G Leads $50 Million Series C In bit.bio To Scale Human Cell Programming
M&G Investments (M&G) announces that it has led a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pionee...
January 12, 2026 | News
Johnson And Johnson Amivantamab Combo Delivers 73% Response Rate In First Line Metastatic Colorectal Cancer
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable res...
January 12, 2026 | News
AirNexis Secures Global Rights To Phase 2 COPD Asset AN01 In $200 Million Series A Backed By Frazier And OrbiMed
AirNexis acquires exclusive rights to develop AN01 outside of China from Haisco Pharmaceutical Group Company founded by Frazier Life Sciences, which led...
January 12, 2026 | News
Biocytogen And Acepodia Advance Dual Payload Bispecific ADC Strategy Through Option Based Licensing Pact
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), announced that the companies have entered int...
January 12, 2026 | News
Zai Lab Secures China Approval For AUGTYRO In NTRK Fusion Positive Solid Tumours
-Zai Lab Limited announced that China’s National Medical Products Administration (NMPA) has approved the supplemental New Drug Application (sND...
January 09, 2026 | News
Oxeia Targets First Ever Treatment For Persistent Concussion Symptoms After Strong Phase 2a Results
Biotech showed 85% patient improvement in Phase 2a trial—zero approved treatments exist for persistent concussion symptoms Oxeia Biopharmaceuticals ...
January 09, 2026 | News
Lilly To Acquire Ventyx Biosciences In $1.2 Billion Deal To Deepen Oral Inflammation Pipeline
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation Acquisition builds on ...
January 09, 2026 | News
Nuclera Secures First Commercial Sales In Asia With Landmark Installations In Taiwan
Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asi...
January 08, 2026 | News
Most Read
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
